80 FR 149 pgs. 46323-46324 - Manufacturer of Controlled Substances Registration: Sigma Aldrich Research Biochemicals, Inc.
Type: NOTICEVolume: 80Number: 149Pages: 46323 - 46324
Pages: 46323, 46324Docket number: [Docket No. DEA-392]
FR document: [FR Doc. 2015-19166 Filed 8-3-15; 8:45 am]
Agency: Justice Department
Sub Agency: Drug Enforcement Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Manufacturer of Controlled Substances Registration: Sigma Aldrich Research Biochemicals, Inc.
ACTION:
Notice of registration.
SUMMARY:
Sigma Aldrich Research Biochemicals, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Sigma Aldrich Research Biochemicals, Inc. registration as a manufacturer of those controlled substances.
SUPPLEMENTARY INFORMATION:
[top] By notice dated April 14, 2015, and published in the Federal Register on April 22, 2015,
The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Sigma Aldrich Research Biochemicals, Inc. to manufacture the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance of effective controls against diversion by inspecting and testing the company's physical security systems, verifying the company's compliance with state and local laws, and reviewing the company's background and history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above-named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed:
| Controlled substance | Schedule |
|---|---|
| Cathinone (1235) | I |
| Methcathinone (1237) | I |
| Mephedrone (4-Methyl-N-methylcathinone) (1248) | I |
| Aminorex (1585) | I |
| Alpha-ethyltryptamine (7249) | I |
| Lysergic acid diethylamide (7315) | I |
| Tetrahydrocannabinols (7370) | I |
| 4-Bromo-2,5-dimethoxyamphetamine (7391) | I |
| 4-Bromo-2,5-dimethoxyphenethylamine (7392) | I |
| 4-Methyl-2,5-dimethoxyamphetamine (7395) | I |
| 2,5-Dimethoxyamphetamine (7396) | I |
| 3,4-Methylenedioxyamphetamine (7400) | I |
| N-Hydroxy-3,4-methylenedioxyamphetamine (7402) | I |
| 3,4-Methylenedioxy-N-ethylamphetamine (7404) | I |
| 3,4-Methylenedioxymethamphetamine (7405) | I |
| Dimethyltryptamine (7435) | I |
| Psilocybin (7437) | I |
| 5-Methoxy-N,N-diisopropyltryptamine (7439) | I |
| 1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) | I |
| N-Benzylpiperazine (7493) | I |
| MDPV (3,4-Methylenedioxypyrovalerone) (7535) | I |
| Methylone (3,4-Methylenedioxy-N-methylcathinone) (7540) | I |
| Heroin (9200) | I |
| Normorphine (9313) | I |
| Amphetamine (1100) | II |
| Methamphetamine (1105) | II |
| Nabilone (7379) | II |
| 1-Phenylcyclohexylamine (7460) | II |
| Phencyclidine (7471) | II |
| Cocaine (9041) | II |
| Codeine (9050) | II |
| Ecgonine (9180) | II |
| Levomethorphan (9210) | II |
| Levorphanol (9220) | II |
| Meperidine (9230) | II |
| Metazocine (9240) | II |
| Methadone (9250) | II |
| Morphine (9300) | II |
| Thebaine (9333) | II |
| Levo-alphacetylmethadol (9648) | II |
| Remifentanil (9739) | II |
| Sufentanil (9740) | II |
| Carfentanil (9743) | II |
| Fentanyl (9801) | II |
The company plans to manufacture reference standards.
Dated: July 29, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-19166 Filed 8-3-15; 8:45 am]
BILLING CODE P